Biotech · Private company
B. Braun Medical Inc.
Track this companyFree. Adds B. Braun Medical Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials50 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- Cefazolin 3gm for Injection USP and Dextrose Injection USPPhase 1 · InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- B. Braun Peripheral Advantage (PA) ProgramComplications Associated With DeviceClinicalTrials.gov · fetched Nov 12, 2026
- Cefazolin 1 g InfusionPostoperative InfectionClinicalTrials.gov · fetched Nov 12, 2026
- Cefazolin 2 g InfusionPostoperative InfectionClinicalTrials.gov · fetched Nov 12, 2026
- Prontosan Wound Irrigation Solution and Prontosan Wound GelWound of Lower Leg (Physical Finding)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Pharmacokinetics and Safety of Cefazolin 3gm DUPLEX in AdultsPHASE1 · COMPLETED · started Apr 5, 2022ClinicalTrials.gov NCT05205486 · fetched Nov 12, 2026
- Effect of B. Braun Peripheral Advantage Program on Complications, Indwell Time and First Stick Success of PIVC TherapyNA · TERMINATED · started Jan 24, 2020ClinicalTrials.gov NCT04048863 · fetched Nov 12, 2026
- Comparison of Clorotekal and Bupivacaine for Short Obstetric SurgeryPHASE4 · SUSPENDED · started Oct 24, 2019ClinicalTrials.gov NCT03967288 · fetched Nov 12, 2026
- Prontosan Quality of Life Study in Patients With Chronic Leg Wound(s)NA · TERMINATED · started Feb 20, 2018ClinicalTrials.gov NCT03369756 · fetched Nov 12, 2026
- Safety of 1 g and 2 g of Cefazolin in Pediatric SubjectsPHASE4 · TERMINATED · started Nov 20, 2017ClinicalTrials.gov NCT03231228 · fetched Nov 12, 2026